|
Real-time Estimate
Cboe BZX
15:02:29 2026-10-27 EDT
|
5-day change | 1st Jan Change | ||
| 12.10 USD | +6.70% |
|
+1.54% | +222.68% |
| 09-25 | SELLAS Life Sciences Presents Preclinical Data Demonstrating SLS009 Activity in Pancreatic Cancer Models at the 2026 AACR Conference on Pancreatic Cancer | CI |
| 09-14 | Top Premarket Decliners | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +6.70% | +1.54% | +4.96% | +12.28% | +222.68% | +527.06% | +1,200.24% | +42.28% | - | 2.29B | |
| -3.10% | -3.43% | -12.88% | +13.18% | +56.09% | +36.29% | +67.69% | +1.93% | - | 65.28B | |
| +0.33% | +0.33% | -7.32% | -0.89% | +9.21% | +10.16% | +78.07% | +225.62% | +5,451.77% | 54.57B | |
| +0.16% | +1.73% | +8.83% | +13.66% | +18.22% | +9.89% | +102.10% | -15.79% | +259.62% | 53.59B | |
| +0.07% | +1.68% | +0.51% | +27.73% | +20.82% | +25.26% | +51.36% | +7.10% | +277.74% | 45.03B | |
| -1.52% | -5.04% | -0.51% | +12.03% | +20.18% | +15.75% | +114.21% | -0.59% | +1,012.83% | 42.17B | |
| +1.40% | -5.06% | -7.50% | -0.78% | +134.27% | +221.78% | +902.69% | +576.33% | - | 39.42B | |
| -0.74% | -4.84% | +6.31% | +6.19% | +9.41% | +14.53% | +44.45% | +3.10% | +154.40% | 32.71B | |
| -2.70% | -7.34% | -15.74% | +14.22% | +42.05% | +23.17% | +0.36% | -62.78% | - | 24.01B | |
| +1.11% | +15.18% | +30.19% | +57.08% | +47.85% | +60.27% | +49.33% | +3.20% | +162.43% | 26.5B | |
| +0.36% | -4.67% | -12.28% | -4.59% | -8.71% | -18.05% | -4.70% | -68.82% | - | 21.82B | |
| +1.29% | -1.20% | -19.67% | -9.74% | -45.69% | -42.37% | +295.83% | +258.05% | +586.95% | 20.38B | |
| -0.18% | +8.29% | +9.53% | +14.47% | +20.12% | +13.10% | +169.55% | +220.34% | +2,247.39% | 18.93B | |
| -0.06% | +13.05% | +21.06% | +58.99% | +78.77% | +82.62% | +106.63% | -17.08% | +366.29% | 17.06B | |
| -0.58% | +8.20% | +8.59% | +27.73% | +36.99% | +38.81% | +84.70% | -16.52% | +107.58% | 16.69B | |
| -0.23% | +0.90% | +11.31% | +16.41% | +48.23% | +62.47% | +221.63% | +205.02% | +494.96% | 16.13B | |
| +0.18% | +5.04% | +7.00% | -2.87% | - | - | - | - | - | 16.1B | |
| +2.59% | +1.28% | +3.03% | +4.85% | +180.86% | +162.43% | +375.61% | +1,411.75% | +779.81% | 14.75B | |
| -0.07% | +4.85% | +4.02% | +8.21% | +0.23% | +0.33% | -22.39% | -35.18% | +126.93% | 14.18B | |
| -5.62% | +0.27% | -2.96% | -11.83% | +15.55% | +3.56% | +512.43% | - | - | 14.63B | |
| Average | -0.04% | +4.29% | +1.82% | +12.82% | +47.74% | +65.64% | +228.94% | +152.11% | +925.29% | 27.81B | |
| Weighted average by Cap. | -0.46% | +2.94% | -0.10% | +12.64% | +37.42% | +41.36% | +168.56% | +122.49% | +1,233.74% |
- Stock Market
- Stocks
- SLS Stock
- Sector SELLAS Life Sciences Group, Inc.
Select your edition
All financial news and data tailored to specific country editions
